Skip to main content
Top
Published in: International Journal of Clinical Oncology 6/2013

01-12-2013 | Original Article

Short-term functional and oncological outcomes of partial nephrectomy for renal cell carcinoma in patients with an anatomically or functionally solitary kidney: single-center experience

Authors: Takeshi Maehana, Toshiaki Tanaka, Hiroshi Kitamura, Naoya Masumori, Taiji Tsukamoto

Published in: International Journal of Clinical Oncology | Issue 6/2013

Login to get access

Abstract

Background

We retrospectively investigated short-term functional and oncological outcomes of partial nephrectomy (PN) for the anatomically or functionally solitary kidney in patients with renal cell carcinoma.

Methods

Between 1993 and 2011, 193 partial nephrectomies were performed and 16 (8.3 %) had an imperative indication in our institution. The patients’ characteristics, peri- and postoperative complications, surgical margin status and postoperative changes in estimated glomerular filtration rates (eGFR) were assessed.

Results

The median follow-up period was 31.2 months and median age was 69.5 years. Open and laparoscopic PN were performed for 13 and 2 patients, respectively. One patient received ex-vivo PN followed by autotransplantation. There was no case with a positive surgical margin. All patients survived at the final day of observation. Median preoperative eGFR was 48.67 mL/min/1.73 m2 and the reduction rate of eGFR at 3 months after operation was 20.9 % (0–50.2). Three patients (18.8 %) required temporary hemodialysis after operation and all these patients had stage 4 chronic kidney disease (CKD) before operation. Only one patient needed chronic hemodialysis at 8 months after operation.

Conclusions

PN can be performed safely and provides feasible functional and oncological outcomes. Preoperative CKD stage 4 patients may have a risk of temporary hemodialysis in the perioperative period.
Literature
1.
go back to reference Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279PubMedCrossRef Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279PubMedCrossRef
2.
go back to reference Fergany AF, Saad IR, Woo L et al (2006) Open partial nephrectomy for tumor in a solitary kidney: experience with 400 cases. J Urol 175:1630–1633PubMedCrossRef Fergany AF, Saad IR, Woo L et al (2006) Open partial nephrectomy for tumor in a solitary kidney: experience with 400 cases. J Urol 175:1630–1633PubMedCrossRef
3.
go back to reference La Rochelle J, Shuch B, Riggs S et al (2009) Functional and oncological outcomes of partial nephrectomy of solitary kidneys. J Urol 181:2037–2042PubMedCrossRef La Rochelle J, Shuch B, Riggs S et al (2009) Functional and oncological outcomes of partial nephrectomy of solitary kidneys. J Urol 181:2037–2042PubMedCrossRef
4.
go back to reference Lane BR, Novick AC, Babineau D et al (2008) Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. J Urol 179:847–851PubMedCrossRef Lane BR, Novick AC, Babineau D et al (2008) Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. J Urol 179:847–851PubMedCrossRef
5.
go back to reference Raman JD, Raj GV, Lucas SM et al (2010) Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int 105:496–500PubMedCrossRef Raman JD, Raj GV, Lucas SM et al (2010) Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int 105:496–500PubMedCrossRef
6.
go back to reference Haber GP, Lee MC, Crouzet S et al (2012) Tumor in solitary kidney: laparoscopic partial nephrectomy vs laparoscopic cryoablation. BJU Int 109:118–124PubMedCrossRef Haber GP, Lee MC, Crouzet S et al (2012) Tumor in solitary kidney: laparoscopic partial nephrectomy vs laparoscopic cryoablation. BJU Int 109:118–124PubMedCrossRef
7.
go back to reference Uchida K, Takahashi A, Masumori N et al (2004) Partial nephrectomy for small localized renal cell carcinoma. Hinyokika Kiyo 50:389–395PubMed Uchida K, Takahashi A, Masumori N et al (2004) Partial nephrectomy for small localized renal cell carcinoma. Hinyokika Kiyo 50:389–395PubMed
8.
go back to reference Masumori N, Itoh N, Takahashi S et al (2012) New technique with combination of felt, Hem-o-lok and Lapra-Ty for suturing the renal parenchyma in laparoscopic partial nephrectomy. Int J Urol 19:273–276PubMedCrossRef Masumori N, Itoh N, Takahashi S et al (2012) New technique with combination of felt, Hem-o-lok and Lapra-Ty for suturing the renal parenchyma in laparoscopic partial nephrectomy. Int J Urol 19:273–276PubMedCrossRef
10.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind Ch (2009) International Union Against Cancer (UICC) TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, London Sobin LH, Gospodarowicz MK, Wittekind Ch (2009) International Union Against Cancer (UICC) TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, London
11.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCentralPubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCentralPubMedCrossRef
12.
go back to reference Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992PubMedCrossRef Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992PubMedCrossRef
13.
go back to reference Levey AS, Eckardt KU, Tsukamoto Y et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100PubMedCrossRef Levey AS, Eckardt KU, Tsukamoto Y et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100PubMedCrossRef
14.
go back to reference Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31PubMedCentralPubMedCrossRef Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31PubMedCentralPubMedCrossRef
15.
go back to reference Zheng JH, Xu YF, Peng B et al (2009) Retroperitoneal laparoscopic partial nephrectomy for renal-cell carcinoma in a solitary kidney: report of 56 cases. J Endourol 23:1971–1974PubMedCrossRef Zheng JH, Xu YF, Peng B et al (2009) Retroperitoneal laparoscopic partial nephrectomy for renal-cell carcinoma in a solitary kidney: report of 56 cases. J Endourol 23:1971–1974PubMedCrossRef
16.
go back to reference Olweny EO, Park SK, Tan YK et al (2012) Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 61:1156–1161PubMedCrossRef Olweny EO, Park SK, Tan YK et al (2012) Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 61:1156–1161PubMedCrossRef
17.
go back to reference Ghavamian R, Cheville JC, Lohse CM et al (2002) Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol 168:454–459PubMedCrossRef Ghavamian R, Cheville JC, Lohse CM et al (2002) Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol 168:454–459PubMedCrossRef
18.
go back to reference Yossepowitch O, Thompson RH, Leibovich BC et al (2008) Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 179:2158–2163PubMedCentralPubMedCrossRef Yossepowitch O, Thompson RH, Leibovich BC et al (2008) Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 179:2158–2163PubMedCentralPubMedCrossRef
19.
go back to reference Lane BR, Russo P, Uzzo RG et al (2011) Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol 185:421–427PubMedCrossRef Lane BR, Russo P, Uzzo RG et al (2011) Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol 185:421–427PubMedCrossRef
20.
go back to reference Ninomiya T, Kiyohara Y, Kubo M et al (2005) Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 68:228–236PubMedCrossRef Ninomiya T, Kiyohara Y, Kubo M et al (2005) Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 68:228–236PubMedCrossRef
Metadata
Title
Short-term functional and oncological outcomes of partial nephrectomy for renal cell carcinoma in patients with an anatomically or functionally solitary kidney: single-center experience
Authors
Takeshi Maehana
Toshiaki Tanaka
Hiroshi Kitamura
Naoya Masumori
Taiji Tsukamoto
Publication date
01-12-2013
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 6/2013
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-012-0484-7

Other articles of this Issue 6/2013

International Journal of Clinical Oncology 6/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine